Insider · CIK 0001197014
John J Alam
Files at CRVO (CervoMed Inc.). First filing Nov 13, 2025, latest Nov 19, 2025.
In brief
John J Alam files SEC Form 4 as CEO, president, director and 10% owner at CRVO (CervoMed Inc.). Since Nov 13, 2025, John J Alam has reported 3 open-market buys worth $283k and 0 open-market sells worth $0, the latest filed on Nov 19, 2025.
A track record needs three past buys with six months of prices behind them; John J Alam has 0, so none is measured yet.
The newest scored trade: bought $183k of CRVO on Nov 17, 2025, filed Nov 19, 2025, scored 57 (moderate). In the last 12 months: 3 buys worth $283k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRVO: CervoMed Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | CervoMed Inc. | $183k 21,600 shares | +1% | - | |
| 47Moderate | CervoMed Inc. | $59k 7,847 shares | +1% | - | |
| 41Moderate | CervoMed Inc. | $41k 5,553 shares | +0% | - |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Spouse | +8,150 | $0.00 | $0 | 8,150 | Jun 10, 2026 |
| Feb 11, 2026 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Feb 13, 2026 |
| Nov 17, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +10,807 | $8.46 | $91k | 1,484,078 | Nov 19, 2025 |
| Nov 17, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stockindirect: Spouse's IRA | +10,793 | $8.46 | $91k | 12,500 | Nov 19, 2025 |
| Nov 13, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +4,447 | $7.51 | $33k | 1,471,578 | Nov 17, 2025 |
| Nov 14, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +1,693 | $7.55 | $13k | 1,473,271 | Nov 17, 2025 |
| Nov 14, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stockindirect: Spouse's IRA | +1,707 | $7.57 | $13k | 1,707 | Nov 17, 2025 |
| Nov 12, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +5,553 | $7.35 | $41k | 1,467,131 | Nov 13, 2025 |
| Jun 23, 2025 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivativeindirect: By Spouse | +8,100 | $0.00 | $0 | 8,100 | Jun 25, 2025 |
| Feb 4, 2025 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Feb 14, 2025 |
Questions about John J Alam
Answered from the filings on this page, as of the latest one.
Is John J Alam buying or selling?
In the last 12 months John J Alam reported 3 open-market buys worth $283k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $183k of CRVO on Nov 17, 2025. Grants, option exercises and tax withholding are not counted.
How did John J Alam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John J Alam has 0.
Where does John J Alam file Form 4?
John J Alam has filed Form 4 at CRVO (CervoMed Inc.) as CEO & President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.